The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2022
Filed:
Mar. 26, 2015
Applicant:
Purdue Pharmaceutical Products L.p., Stamford, CT (US);
Inventors:
Thomas Mehrling, Basel, CH;
Claudio Festuccia, L'Aquila, IT;
Assignee:
Purdue Pharmaceutical Products L.P., Stamford, CT (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4184 (2006.01); A61K 38/06 (2006.01); A61K 31/407 (2006.01); A61K 31/427 (2006.01); A61K 31/5377 (2006.01); A61K 31/573 (2006.01); A61K 31/58 (2006.01); A61K 31/69 (2006.01); A61K 38/05 (2006.01); A61K 31/502 (2006.01); A61K 31/55 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A61K 31/407 (2013.01); A61K 31/427 (2013.01); A61K 31/502 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 31/69 (2013.01); A61K 38/05 (2013.01); A61K 38/06 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01);
Abstract
There is provided a compound of formula I or a pharmacologically acceptable salt thereof: for use in the treatment of a brain cancer selected from a MGMT positive astrocytic brain tumor, a metastatic brain cancer and primary CNS lymphoma and a method of treating said brain cancers in a patient in need thereof comprising administering to the patient said compound of formula I or a pharmacologically acceptable salt thereof.